Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany-Reference-Cited by-同舟云学术

Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany

Published:2023-02-21 Issue:4 Volume:51 Page:1177-1178
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Montag Karsten,Kampf Günter

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s15010-023-02003-0.pdf

Reference4 articles.

1. Montag K, Kampf G. Acute lower respiratory tract infections accounted for 56.2% of hospitalized COVID-19 cases in Germany during the first three waves. Int J Epidemiol. 2022;51:1032–3.

2. Lange B, Jäger VK, Rücker V, et al. 2. Interimsanalyse des IMMUNEBRIDGE- Projektes zur Kommunikation von vorläufigen Ergebnissen an das Modellierungsnetz für schwere Infektionskrankheiten. 2022. https://www.bmbf.de/SharedDocs/Downloads/de/2022/20221013-zwischenbericht-immunbridge.pdf?__blob=publicationFile&v=2.

3. Leiner J, Pellissier V, Hohenstein S, et al. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals. BMC Infect Dis. 2022;22:802. https://doi.org/10.1186/S12879-022-07781-W.

4. Institut für das Entgeltsystem im Krankenhaus. InEK Datenportal. https://www.g-drg.de/InEK_Datenportal.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Face Masking on Transmission of SARS-CoV-2;Advances in Experimental Medicine and Biology;2024

2. Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations;The Lancet Infectious Diseases;2023-08